Abstract Details

Title Targeting the Dystrophia Myotonica Protein Kinase (DMPK) Gene To Reduce RNA Toxicity

Topic Muscle Disease/Neuromuscular Junction

Presentation(s) (-)

Poster/Presentation
Number 002

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Clifford J. Beall, PhD	No disclosure on file
Jerry R. Mendell, MD, FAAN (The Research Institute at Nationwide Children's Hospital)	Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics . The institution of Dr. Mendell has received research support from Sarepta.
K. Reed Clark, PhD	No disclosure on file
Clotilde Balucani, MD, PhD	Dr. Balucani has nothing to disclose.

��ɫ����